Concourse Financial Group Securities, Inc. Abbott Laboratories Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 5,346 shares of ABT stock, worth $626,871. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,346

Previous 5,381 0.65%

Holding current value

$626,871

Previous $559,000 8.94%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $3,502 - $4,134	-35 Reduced 0.65%	5,346 $609,000
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $50,264 - $56,107	-499 Reduced 8.49%	5,381 $559,000
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $89,149 - $98,461	814 Added 16.07%	5,880 $668,000
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $6,854 - $8,390	76 Added 1.52%	5,066 $557,000
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $20,061 - $24,070	-210 Reduced 4.04%	4,990 $483,000
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $80,120 - $89,270	-795 Reduced 13.26%	5,200 $566,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $177,834 - $209,322	-1,836 Reduced 23.45%	5,995 $607,000
Q4 2022 Jan 30, 2023	BUY	$95.06 - $111.52 $744,414 - $873,313	7,831 New	7,831 $0
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $701,993 - $812,777	-7,255 Closed	0 $0
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $107,275 - $129,661	1,051 Added 16.94%	7,255 $788,000
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $1.24 Million - $1.52 Million	-10,907 Reduced 63.74%	6,204 $734,000
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $7,162 - $8,770	62 Added 0.36%	17,111 $2.41 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $6,416 - $7,098	55 Added 0.32%	17,049 $2.01 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $107,376 - $126,397	1,015 Added 6.35%	16,994 $1.97 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $19,917 - $23,466	183 Added 1.16%	15,979 $1.92 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $182,175 - $198,518	1,735 Added 12.34%	15,796 $1.73 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $138,376 - $168,047	1,510 Added 12.03%	14,061 $1.53 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $26,646 - $34,104	348 Added 2.85%	12,551 $1.15 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $766,592 - $1.12 Million	12,203 New	12,203 $963,000
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $11,784 - $12,778	-144 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $737,035 - $859,605	-10,113 Reduced 98.6%	144 $12,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $150,518 - $181,976	-2,273 Reduced 18.14%	10,257 $819,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $686,675 - $777,903	10,474 Added 509.44%	12,530 $906,000
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $125,025 - $150,828	2,056 New	2,056 $151,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Abbott Laboratories Transaction History